학술논문
Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure.
Document Type
Article
Author
Source
ESC Heart Failure; Aug2021, Vol. 8 Issue 4, p2580-2590, 11p
Subject
Language
ISSN
20555822
Abstract
Copyright of ESC Heart Failure is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)